Bleomycin genotoxicity and amifostine (WR-2721) cell protection in normal leukocytes vs. K562 tumoral cells

Biochemical Pharmacology

Volumn 63, Issue 5, 2002, Pages 967-975

  Buschini, Annamaria ^a   Alessandrini, Chiara ^a   Martino, Anna ^a   Pasini, Luca ^a   Rizzoli, Vittorio ^a   Carlo Stella, Carmelo ^b   Poli, Paola ^a   Rossi, Carlo ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Antiblastic drugs; Chemoprotection; Chemotheraphy; Comet assay; DNA damage; Individual variability

Indexed keywords

AMIFOSTINE; BLEOMYCIN;

ARTICLE; CANCER CHEMOTHERAPY; CELL PROTECTION; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG MEGADOSE; DRUG SELECTIVITY; GEL ELECTROPHORESIS; GENETIC DIFFERENCE; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; MYELOID LEUKEMIA; PRIORITY JOURNAL; TUMOR CELL LINE;

AMIFOSTINE; ANTIMETABOLITES, ANTINEOPLASTIC; BLEOMYCIN; DNA DAMAGE; DRUG INTERACTIONS; HUMANS; K562 CELLS; LEUKOCYTES; MUTAGENICITY TESTS; PROTECTIVE AGENTS;

EID: 0036497124     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00926-1     Document Type: Article

References (27)

1. Chemoprotection in anticancer therapy: The emerging role of amifostine (WR-2721)
2. Amifostine: A selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity
3. In vitro antioxidant properties of amifostine (WR-2721, ethyol)
4. In vitro effect of amifostine on haematopoietic progenitors exposed to carboplatin and non-alkylating antineoplatic drugs: Haematoprotection acts as a drug-specific progenitor rescue
5. Genotoxicity of bleomycin
6. DNA damage induced by bleomycin, neocarzinostatin, and melphalan in a precisely positioned nucleosome: Asymmetry in protection at the periphery of nucleosome-bound DNA
7. Mechanisms of bleomycin-induced DNA degradation
8. DNA strand breakage in isolated nuclei subjected to bleomycin or hydrogen peroxide
9. Modulation of bleomycin-induced mitotic recombination in yeast by the aminothiols cysteamine and WR-1065
10. DNA damage and mutagenesis by radiomimetic DNA cleaving agents: Bleomycin, neocarzinostatin and other enediynes
11. Glutathione metabolism as a determinant of therapeutic efficacy: A review
12. Potentiation of chemotherapy cytotoxicity following iododeoxyuridine incorporation in Chinese hamster cells
13. Changes in glutathione content and resistance to anticancer agents in human stomach cancer cells induced by treatments with melphalan in vitro
14. Differential sensitivities of murine melanocytes and melanoma cells to buthionine sulfoximine and anticancer drugs
15. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine
16. Amifostine modulation of bleomycin-induced lung injury in rodents
17. Exacerbation of bleomycin-induced lung injury in mice by amifostine
18. A simple technique for quantitation of low levels of DNA damage in individual cells
19. The Comet assay: A comprehensive review
20. The single cell gel electrophoresis assay (Comet assay): A European review
21. Use of the Comet test in the evaluation of multidrug resistance of human cell lines
22. Amifostine (WR-2721) selective protection against melphalan genotoxicity
23. Induction of DNA strand breaks associated apoptosis during treatment of leukaemia
24. Amifostine protects normal tissue from paclitaxel toxicity while cytotoxicity against tumour cells is maintained
25. Amifostine (WR-2721) shortens the engraftment period of 4-hydroxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support
26. Amifostine improves the antileukemic therapeutic index of mafosfamide: Implications for bone marrow purging
27. Protein adducts as dosimeters of human exposure to styrene, styrene-7,8-oxide, and benzene